Interferon-alpha, cytokines and possible implications for mood disorders

Bipolar Disorders

Volumn 4, Issue SUPPL. 1, 2002, Pages 111-113

  Schaefer, Martin ^a   Schmidt, Folkart ^b   Neumer, Ruth ^a   Scholler, Gudrun ^a   Schwarz, Markus ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

AFFECTIVE NEUROSIS; ARTICLE; BLOOD BRAIN BARRIER; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CHILL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; FEVER; HEPATITIS C; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOMODULATION; LIFE EVENT; MANIC DEPRESSIVE PSYCHOSIS; MELANOMA; MENTAL DISEASE; MYALGIA; NAUSEA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STRESS; SUICIDE;

CYTOKINES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-ALPHA; MOOD DISORDERS; RECEPTORS, INTERLEUKIN; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0036385164     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.4.s1.52.x     Document Type: Article

References (20)

1. Song C, Leonard BE. Fundamentals of Psychoneuroimmunology. New York: Wiley, 2000.
2. Schaefer M, Engelbrecht MA, Gut O et al. Interferon alpha and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 1-16.
3. Cirelly R, Tyring SK. Major therapeutic uses of interferons. Clin immunother 1995; 3: 27-87.
4. Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Mood and cognitive side effects of Interferon-α therapy. Semin Oncol 1998; 25 (Suppl. 1): S39-S47.
5. Greenberg DB, Lonasch E, Gadd MA et al. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Gabapentin may serve as a mood stabilizer. Cancer 2000; 89: 356-362.
6. Janssen HL, Brouwer JT, van der Mast RC, Shalm SW. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 1994; 21: 241-243.
7. Nozaki O, Takagi C, Takaoka K, Takata T, Yoshida M. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Psychiatry Clin Neurosci 1997; 51: 175-180.
8. Strite D, Valentine AD, Meyers CA. Manic episodes in two patients treated with interferon alpha. J Neuropsych Clin N 1997; 9: 273-276.
9. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 38-47.
10. Renault PF, Hoofnagle JH, Park Y et al. Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987; 147: 1577-1580.
11. Rifflet H, Vuillemin E, Oberti F, Duverger P, Garre JB, Cales P. Suicidal impulses in patients with chronic viral hepatitis C treated by alpha interferon. Gastroen Clin Biol 1998; 22: 353-357.
12. Thomas AJ, Ferrier IN, Kalaria RN, et al. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry 2000; 157: 1682-1684.
13. Risau W, Esser S, Engelhardt B. Differentiation of blood-brain barrier endothelial cells. Pathol Biol 1998; 46: 171-175.
14. Engelhardt B, Conley FK, Burtcher EC. Cell adhesion molecules on vessels during inflammation in the mouse central nervous system. J Neuroimmunol 1994; 51: 199-208.
15. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157: 683-694.
16. Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 2001; 15: 7-24.
17. Yirmiya R, Pollak Y, Morak M et al. Illness, cytokines, and depression. Ann NY Acad Sci 2000; 917: 478-487.
18. Yamano M, Yuki H, Yasuda S, Miyata K. Corticotropin-releasing hormone 1 receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice. J Pharmacol Exp Ther 2000; 292: 181-187.
19. Song C. The interaction between cytokines and neurotransmitters in depression and stress: possible mechanism of antidepressant treatments. Hum Psychopharmacol Clin Exp 2000; 15: 199-211.
20. Reichenberg A, Yirmia R, Schuld A et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001; 58: 445-452.